导读丁型肝炎病毒（hepatitis D virus，HDV）感染可导致严重形式的慢性病毒性肝炎，但其对乙型肝炎病毒（hepatitis B virus，HBV）肝硬化患者发生肝细胞癌（Hepatocellular ...

Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...

There were 43 892 people with HBV monoinfection, and 83 817 with HCV monoinfection in the final study cohort, of which 13 645 (31%) and 35 615 (43%), respectively, had a linked hospital record ...

Hepatitis B virus (HBV) infection contributes to hepatocellular carcinoma (HCC) tumorigenesis, drug resistance, and recurrence, although the underlying molecular mechanisms remain unclear.

The therapy showed substantial antiviral activity in individuals with advanced HBV-related hepatocellular carcinoma. Credit: Orawan Pattarawimonchai/Shutterstock. SCG ...

In the Phase 1 clinical trial, SCG101 exhibited promising antiviral activity in patients with advanced HBV-related hepatocellular carcinoma (HBV-HCC). Among the 12 patients treated with a single ...

HBV remains a major global health burden, affecting over 250 million people worldwide. It is a leading cause of liver cancer, responsible for 50%–80% of hepatocellular carcinoma cases globally.

SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T-cell receptor-engineered T Cell (TCR-T) therapy, SCG101. The therapy ...

Hepatitis, particularly types B and C, has a profound impact on liver health, often leading to serious conditions like cirrhosis and liver cancer. These viral infections initiate an inflammatory ...